Knowledge Bomb

Knowledge Bomb: Antiplatelet Therapy in Ischemic Stroke

We continue the series with Knowledge Bomb #22. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background Ischemic stroke remains amongst the top five causes of death world wide impacting 6.2 million people annually¹. In the United States, 140K Americans die each year from stroke².

Knowledge Bomb

Knowledge Bomb: Route of Diltiazem in Afib with RVR

We continue the series with Knowledge Bomb #21. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background Atrial fibrillation (afib) with rapid ventricular rate (RVR) can lead to adverse effects on cardiovascular hemodynamics. Sustained elevated rates of disorganized atrial electrical activity leads to the absence

Knowledge Bomb

Knowledge Bomb: Fluid Resuscitation in Pediatric DKA

We continue the series with Knowledge Bomb #20. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background Cerebral edema is one of the most feared complications in pediatric patients with diabetic ketoacidosis (DKA). It is the leading cause of death from this disease process. Thankfully

Knowledge Bomb

Knowledge Bomb: High-Velocity Nasal Insufflation for Respiratory Failure

We continue the series with Knowledge Bomb #19. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background Dyspnea and acute respiratory failure are among the top 5 reasons for patients to present to the Emergency Department. High-velocity nasal insufflation (HVNI), a type of high-flow nasal

Knowledge Bomb

Knowledge Bomb: TXA for Epistaxis

We continue the series with Knowledge Bomb #18. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background It’s a busy ER shift. Everyone seems pretty sick today. You get a patient into a back room of your emergency department with a pretty bad nosebleed. The

Knowledge Bomb

Knowledge Bomb: Observation for Heroin Overdose After Receiving Naloxone

We continue the series with Knowledge Bomb #17. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background As EM docs we see a lot of opiate overdose cases, usually heroin. As a resident learning from attendings, who have different practice patterns, I have noticed varying

Knowledge Bomb

Knowledge Bomb: LP for Complex Febrile Seizures

We continue the series with Knowledge Bomb #16. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background Simple febrile seizures are common in the pediatric population, ages 6 months to 5 years. However, complex febrile seizures are more rare, affecting less than 1% of children.

Knowledge Bomb

Knowledge Bomb: LOV-ED Trial

We continue on with the series with Knowledge Bomb #15. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background: Annually, 250,000 patients are mechanically ventilated in US Emergency Departments (ED). Of these patients, 20% will develop complications such as Acute Respiratory Distress Syndrome (ARDS) or

Knowledge Bomb

Knowledge Bomb: Antibiotics Versus Surgery for Appendicitis

We continue on with the series with Knowledge Bomb #14. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background The inspiration behind choosing this article came from a case I had in the Emergency Department involving acute uncomplicated appendicitis. The patient was a 30-year-old male

Knowledge Bomb

Knowledge Bomb: Outcomes of New Onset Afib/Aflutter in ER Patients

We continue on with the series with Knowledge Bomb #13. The purpose and motivation for this series is outlined in the first entry and extensively in an ALiEM IDEA series blog entry. Background In the United States, we are more inclined to focus on rate control for new onset atrial fibrillation (afib) in the ER rather